BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 437670)

  • 1. Electrophysiological studies in patients with the Wolf-Parkinson-White syndrome.
    Farré J; Ross DL; Wiener I; Bär FW; Vanagt E; Wellens HJ
    Herz; 1979 Feb; 4(1):38-46. PubMed ID: 437670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
    Duckeck W; Kuck KH
    Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arrhythmias in the Wolff-Parkinson-White syndrome (author's transl)].
    Lüderitz B; Steinbeck G
    MMW Munch Med Wochenschr; 1976 Mar; 118(12):377-82. PubMed ID: 817167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ventricular pre-excitation: electrophysiopathology, criteria for interpretation and clinical diagnosis. References for geriatrics].
    Tamburrini LR; Fontanelli A; Primossi G
    Minerva Cardioangiol; 2001 Feb; 49(1):47-73. PubMed ID: 11279385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
    Jiang H
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessory pathway reciprocating tachycardia.
    Obel OA; Camm AJ
    Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
    Centurión OA; Shimizu A; Isomoto S; Konoe A
    Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transesophageal study in the diagnostic evaluation of pre-excitation].
    Favale S; Pitzalis MV; Totaro P; Di Biase M; Rizzon P
    Cardiologia; 1991 Aug; 36(8 Suppl):75-80. PubMed ID: 1817775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and electrophysiological indications for surgical treatment in patients with Wolff-Parkinson-White syndrome].
    Walczak F; Biederman A; Jedynak Z; Rembelska H; Kepski R; Sliwiński M; Hoffman M
    Kardiol Pol; 1992 Mar; 36(3):146-50. PubMed ID: 1608182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome].
    Mabo P; Kermarrec A; Gras D; Paillard F; Bédossa M; Daubert C
    Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern.
    Klein GJ; Yee R; Sharma AD
    N Engl J Med; 1989 May; 320(19):1229-33. PubMed ID: 2710202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the anti-arrhythmia agent ethmozin on the refractory period of the accessory pathway in Wolff-Parkinson-White syndrome].
    Rakovec P; Kenda MF
    Wien Med Wochenschr; 1986 Feb; 136(3):65-6. PubMed ID: 3515775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.
    Waspe LE; Brodman R; Kim SG; Fisher JD
    Am Heart J; 1986 Dec; 112(6):1141-52. PubMed ID: 3788760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
    Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
    Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical atrioventricular disconnection in Wolff-Parkinson-White syndrome].
    Pavie A; Mesnildrey P; Gandjbakhch I; Cabrol C; Fontaine G; Franck R; Grosgogeat Y; Slama R
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):606-15. PubMed ID: 6431924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome].
    Kieny JR; Kraenner C; Facello A; Roul G; Mossard JM; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data].
    Dolla E; Levy S; Cointe R; Moyal C; Bru P; Rossi P; Gérard R
    Arch Mal Coeur Vaiss; 1991 Jul; 84(7):917-21. PubMed ID: 1929709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of arrhythmias associated with Wolff-Parkinson-White syndrome.
    Conover MB
    Crit Care Nurse; 1994 Jun; 14(3):30-9; quiz 40-1. PubMed ID: 8194348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.